Abstract 1578: Heating it up: Targeting RAS/RAF/PI3K pathway to make melanoma tumors ‘immunologically hot' and suitable for checkpoint blockade immunotherapies
Chi Yan(Vanderbilt University), Ann Richmond, E. Premkumar Reddy(The Graduate Center, CUNY), Caroline A. Nebhan(VA Tennessee Valley Healthcare System), Joseph T. Roland(Vanderbilt University Medical Center), Gregory D. Ayers(Vanderbilt University Medical Center), Sheau‐Chiann Chen(Vanderbilt University Medical Center), Anna E. Vilgelm(The Ohio State University), Rebecca L. Shattuck-Brandt(Vanderbilt University), Nabil Saleh(Ain Shams University), Douglas B. Johnson(Vanderbilt University Medical Center)
Cited by 1
Related Papers
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Drugging the 'undruggable' cancer targets
|Nature reviews. Cancer|2017|912